Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108839684 | 10883968 | 4 | F | 201508 | 20160621 | 20150304 | 20160701 | EXP | BR-ROCHE-1547497 | ROCHE | 53.82 | YR | F | Y | 82.00000 | KG | 20160701 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108839684 | 10883968 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 1.5 AMPULE | Y | 103976 | |||||||||
| 108839684 | 10883968 | 2 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 2.5 UG, QD, (2 ASPIRATIONS) | 0 | 2.5 | UG | QD | |||||||
| 108839684 | 10883968 | 3 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 500/50 UG | 0 | 1 | DF | BID | |||||||
| 108839684 | 10883968 | 4 | C | METICORTEN | PREDNISONE | 1 | Oral | 20 MG, QD,(2 TABLETS IF EPISODE) | 0 | 20 | MG | TABLET | QD | ||||||
| 108839684 | 10883968 | 5 | C | FLIXONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 0 | 2 | DF | SUSPENSION AND SOLUTION FOR SPRAY | BID | |||||||
| 108839684 | 10883968 | 6 | C | CROMOLERG | 2 | Ophthalmic | 1 DRP, QD (IN EACH EYE),4% | 0 | 4 | PCT | TABLET | QD | |||||||
| 108839684 | 10883968 | 7 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
| 108839684 | 10883968 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | .5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108839684 | 10883968 | 1 | Asthma |
| 108839684 | 10883968 | 2 | Asthma |
| 108839684 | 10883968 | 3 | Asthma |
| 108839684 | 10883968 | 4 | Dyspnoea |
| 108839684 | 10883968 | 5 | Prophylaxis |
| 108839684 | 10883968 | 6 | Cataract |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108839684 | 10883968 | HO |
| 108839684 | 10883968 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108839684 | 10883968 | Asthma | |
| 108839684 | 10883968 | Blood potassium decreased | |
| 108839684 | 10883968 | Depressed mood | |
| 108839684 | 10883968 | Fatigue | |
| 108839684 | 10883968 | Hypertension | |
| 108839684 | 10883968 | Obesity | |
| 108839684 | 10883968 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108839684 | 10883968 | 1 | 201408 | 0 | ||
| 108839684 | 10883968 | 2 | 201508 | 0 | ||
| 108839684 | 10883968 | 5 | 201508 | 0 |